Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ZIM Raises Full-Year 2026 Guidance
-
Terreno Realty Corporation Announces Quarterly Operating, Investment and Capital Markets Activity
-
Century Communities Sets Date for Third Quarter 2026 Earnings Release and Conference Call
-
Zeta Global to Acquire Digital Audience, Extending the Zeta Data Cloud Across the Digital Ecosystem
-
Simon® Announces Date For Its Third Quarter 2026 Earnings Release And Conference Call
-
Rocky Mountain Chocolate Factory Announces $6.6 Million Sale-Leaseback of Durango Property
-
Upstart to Announce Third Quarter 2026 Results on November 3, 2026
-
Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia
-
Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface
-
1stDibs to Participate in Upcoming Investor Conference
-
Caribou Biosciences to Evaluate Strategic Alternatives
-
MasterBrand to Announce Third Quarter 2026 Results on November 5
-
Huntsman to Discuss Third Quarter 2026 Results on November 3, 2026
-
Arista Networks to Announce Q3 2026 Financial Results on Tuesday, November 3, 2026
-
PennantPark Investment Corporation Schedules Earnings Release of Fourth Fiscal Quarter 2026 Results
-
The St. Joe Company Announces the Launch of Custom Homesite Sales in Its Newest Watersound® Community
-
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE®
-
Logitech Announces Date for Release of Second Quarter Financial Results for Fiscal Year 2027
-
Medalist Diversified, Inc. Announces Dividend of $0.0675 Per Share on Its Common Stock
-
Zillow Group to Announce Third-Quarter 2026 Results Nov. 4
-
PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Fourth Fiscal Quarter 2026 Results
-
LPL Financial Announces Third Quarter 2026 Earnings Release Date and Conference Call
-
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
-
Constellation Brands Reports Second Quarter Fiscal 2027 Financial Results
-
Encore Capital Group to Announce Third Quarter 2026 Financial Results on November 4
-
Harvard Bioscience Announces Creation of Scientific Advisory Board
-
ScottsMiracle-Gro Names CIO to Accelerate Technology Transformation and SMG 2.0 Growth Strategy
-
Saratoga Investment Corp. Announces Fiscal Second Quarter 2027 Financial Results
-
Itron to Announce Third Quarter Results on October 27, 2026
-
Avista Corp. Third Quarter 2026 Earnings Conference Call and Webcast Announced
-
Astera Labs Announces Conference Call to Review Third Quarter 2026 Financial Results
-
YYForce Opens Singapore Robotics Center to Advance Humanoid Training and Service Robot Deployment
-
Sysco Announces Closing Of $14.65 Billion And €1.0 Billion Notes Offerings
-
Latham Group, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call Date
-
Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026
-
Pyxis Tankers Announces Two-Year Time Charter for Pyxis Lamda at $31,000 per Day
-
Coast Counties Peterbilt Expands into Northern Nevada with Acquisition of Peterbilt Truck Parts & Equipment
-
Best Medical International Celebrates 50 Years of Innovation and Leadership
-
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
-
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Eat Well Group Announces Intention to Settle Approximately $45 Million Recorded NPI Obligation and Accrued Compensation Through Share Issuances
-
Strategic Buyer Acquires Florida MSP as Demand Rises for Managed IT Services
-
Neogen Reports First-Quarter Financial Results for Fiscal Year 2027
-
ChatIQ Leads S&P Global's Latest Capital IQ Pro Update with Expanded AI-Powered Research Capabilities
-
Wynn Resorts Announces Third Quarter Earnings Release Date
-
Intel to Report Third-Quarter 2026 Financial Results
-
BridgeBio to Present Additional Evidence from the Phase 3 CALIBRATE Trial of Encaleret in ADH1 at the ASBMR 2026 Annual Meeting
-
American Coastal Insurance Corporation to Host Investor Webcast on October 13, 2026
-
BridgeBio to Present New Acoramidis Data, Including Independent Comparative Real-World EHR Data at the HFSA Annual Scientific Meeting 2026
-
Acquisition of Own Shares
